搜索医生

Ian F. Parney, M.D., Ph.D.

  1. Neurosurgeon
预约门诊

出版物

  1. Pumford AD, Bauman M, Bouchal S, Riviere-Cazaux C, Jusue-Torres I, Hong S, Neth BJ, Sener U, Parney IF. Neurosurgical Implications of Targeting Hypoxia-Inducible Factor 2alpha in Hemangioblastomas with Belzutifan. World Neurosurg. 2024 Oct; 190:291-296 Epub 2024 Aug 02
    View PubMed
  2. Hotchkiss KM, Karschnia P, Schreck KC, Geurts M, Cloughesy TF, Huse J, Duke ES, Lathia J, Ashley DM, Nduom EK, Long G, Singh K, Chalmers A, Ahluwalia MS, Heimberger A, Bagley S, Todo T, Verhaak R, Kelly PD, Hervey-Jumper S, de Groot J, Patel A, Fecci P, Parney I, Wykes V, Watts C, Burns TC, Sanai N, Preusser M, Tonn JC, Drummond KJ, Platten M, Das S, Tanner K, Vogelbaum MA, Weller M, Whittle JR, Berger MS, Khasraw M. A brave new framework for glioma drug development. Lancet Oncol. 2024 Oct; 25 (10):e512-e519
    View PubMed
  3. Michalopoulos G, Mikula AL, Kerezoudis P, Biedermann AJ, Parney IF, Van Gompel JJ, Bydon M. Unplanned returns to the operating room: a quality improvement methodology for the comparison of institutional outcomes to national benchmarks. J Neurosurg. 2024 Sep 1; 141 (3):804-814 Epub 2024 Apr 12
    View PubMed
  4. Bauman MMJ, Jusue-Torres I, White JJ, Bouchal SM, Hsu AR, Ha Y, Pumford AD, Hong S, Riviere-Cazaux C, Wang K, Brown DA, Helal A, Parney IF. Presentation, surgical outcome, and supplementary motor area syndrome risk of posterior superior frontal gyrus tumors. J Neurosurg. 2024 Aug 30; 1-12 [Epub ahead of print]
    View PubMed
  5. Perez JL, Naylor RM, Bauman MMJ, Harrison DJ, Knowles K, Burns TC, Lanzino G, Link MJ, Peris Celda M, Meyer FB, Van Gompel J, Parney IF. Safety of the immediate use of nonsteroidal anti-inflammatory drugs after adult craniotomy for tumor. J Neurosurg. 2024 Jul 1; 141 (1):117-122 Epub 2024 Feb 02
    View PubMed
  6. Parney IF, Warnick RE, Lang FF, Rutka JT, Kalkanis S, Glick R, Rosenblum ML, Germano IM. The AANS/CNS Section on Tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumors. J Neurosurg. 2024 Jul 1; 141 (1):41-47 Epub 2024 Jan 26
    View PubMed
  7. Benson JC, Trejo-Lopez JA, Cormier JL, Parney IF, Mark IT, Madhavan AA, Kotsenas AL, Rydberg CH, Luetmer PH, Eckel LJ, Johnson DR. Radiology-pathology correlation: Giant tumefactive perivascular spaces. Neuroradiol J. 2024 Apr 12; 19714009241247459 [Epub ahead of print]
    View PubMed
  8. Hong S, Bouchal SM, Bauman MMJ, Riviere-Cazaux C, Pumford AD, Brown PD, Yan ES, Stafford SL, Markovic SN, Link MJ, Burns TC, Jusue-Torres I, Pollock BE, Parney IF. The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgery. J Neurosurg. 2024 Apr 1; 140 (4):938-948 Epub 2023 Sept 29
    View PubMed
  9. Routman DM, Jusue-Torres I, Brown PD, Trifiletti DM, Vora SA, Brown DA, Parney IF, Burns TC, Yan E. Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial. BMC Cancer. 2024 Mar 12; 24 (1):332
    View PubMed
  10. Fain CE, Zheng J, Jin F, Ayasoufi K, Wu Y, Lilley MT, Dropik AR, Wolf DM, Rodriguez RC, Aibaidula A, Tritz ZP, Bouchal SM, Pewe LL, Urban SL, Chen Y, Chang SY, Hansen MJ, Kachergus JM, Shi J, Thompson EA, Jensen HE, Harty JT, Parney IF, Sun J, Wu LJ, Johnson AJ. Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria. Brain. 2024 Feb 1; 147 (2):566-589
    View PubMed
  11. Galanis E, Dooley KE, Keith Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ, Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC, Giannini C, Raghunathan A, Iankov ID, Parney IF. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial. Nat Commun. 2024 Jan 12; 15 (1):493
    View PubMed
  12. Hong S, Garces YI, Price KA, Shinya Y, Parney IF, Link MJ, Pollock BE. Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients. J Neurooncol. 2024 Jan; 166 (2):369-376 Epub 2024 Jan 05
    View PubMed
  13. Inocencio JF, Mitrasinovic S, Asad M, Parney IF, Zang X, Himes BT. Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape. Front Immunol. 2024; 15:1424396 Epub 2024 Sept 13
    View PubMed
  14. Bauman MMJ, Bouchal SM, Kerezoudis P, Cloft H, Brinjikji W, Peris Celda M, Link MJ, Parney IF. Embolization of Large and Giant Posterior Fossa Hemangioblastomas: The Experience of a Single Tertiary Care Center. J Neurol Surg B Skull Base. 2023 Dec; 84 (6):598-608 Epub 2022 Nov 16
    View PubMed
  15. Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W, Bagley SJ, Ashley DM, Kumthekar P, Verhaak R, Chalmers AJ, Patel AP, Watts C, Fecci PE, Batchelor TT, Weller M, Vogelbaum MA, Preusser M, Berger MS, Khasraw M. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nat Med. 2023 Oct; 29 (10):2402-2405
    View PubMed
  16. Mark IT, Black D, Benson JC, Campeau NG, Johnson DR, Messina SA, Giannini C, Parney I, Morris PP. Benign Enhancing Foramen Magnum Lesions. AJNR Am J Neuroradiol. 2023 Sep; 44 (9):999-1001 Epub 2023 Aug 03
    View PubMed
  17. Bhandarkar AR, Bhandarkar S, Babovic-Vuksanovic D, Parney IF, Spinner RJ. Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy. J Neurooncol. 2023 Sep; 164 (3):693-699 Epub 2023 Sept 27
    View PubMed
  18. Cumba Garcia LM, Bouchal SM, Bauman MMJ, Parney IF. Advancements and Technical Considerations for Extracellular Vesicle Isolation and Biomarker Identification in Glioblastoma. Neurosurgery. 2023 Jul 1; 93 (1):33-42 Epub 2023 Feb 07
    View PubMed
  19. Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro Oncol. 2023 Jun 2; 25 (6):1123-1131
    View PubMed
  20. Tritz ZP, Ayasoufi K, Wolf DM, Owens CA, Malo CS, Himes BT, Fain CE, Goddery EN, Yokanovich LT, Jin F, Hansen MJ, Parney IF, Wang C, Moynihan KD, Irvine DJ, Wittrup KD, Diaz Marcano RM, Vile RG, Johnson AJ. Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression. Cancer Immunol Res. 2023 Jun 2; 11 (6):763-776
    View PubMed
  21. Himes BT, Fain CE, Tritz ZP, Nesvick CL, Jin-Lee HJ, Geiger PA, Peterson TE, Jung MY, Parney IF. Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles. J Neurosurg. 2023 May 1; 138 (5):1291-1301 Epub 2022 Sept 16
    View PubMed
  22. Neth BJ, Webb MJ, Parney IF, Sener UT. The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma. Pharmaceutics. 2023 Apr 3; 15 (4) Epub 2023 Apr 03
    View PubMed
  23. Jusue-Torres I, Lee J, Germanwala AV, Burns TC, Parney IF. Effect of Extent of Resection on Survival of Patients with Glioblastoma, IDH-Wild-Type, WHO Grade 4 (WHO 2021): Systematic Review and Meta-Analysis. World Neurosurg. 2023 Mar; 171:e524-e532 Epub 2022 Dec 16
    View PubMed
  24. Jusue-Torres I, Lee J, Germanwala AV, Burns TC, Parney IF. Effect of extent of resection on survival of patients with glioblastoma, idh-wild-type, who grade 4 (who 2021): systematic review and meta-analysis. World Neurosurgery. 2023; 171:E524-32.
  25. Kerezoudis P, Kerezoudi EN, Choudhry A, Himes BT, Parney IF. Complementary and alternative medicine for gliomas: systematic review and critical appraisal of current literature. Neurosurgery. 2023; 92(3):464-71.
  26. Renfrow JJ, Julian BQ, Brown DA, Tatter SB, Laxton AW, Lesser GJ, Strowd RE, Parney IF. A Review on the Surgical Management of Insular Gliomas. Can J Neurol Sci. 2023 Jan; 50 (1):1-9 Epub 2021 Oct 29
    View PubMed
  27. Aibaidula AZ, Fain CE, Garcia LC, Wier A, Bouchal SM, Bauman MM, Jung MY, Sarkaria JN, Johnson AJ, Parney IF. Spectral flow cytometry identifies distinct nonneoplastic plasma extracellular vesicle phenotype in glioblastoma patients. Neurooncol Adv. 2023 Jan-Dec; 5 (1):vdad082 Epub 2023 July 07
    View PubMed
  28. Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S. NCCN Guidelines(R) Insights: Central Nervous System Cancers, Version 2.2022. J Natl Compr Canc Netw. 2023 Jan; 21 (1):12-20
    View PubMed
  29. Lukas RV, Chmura SJ, Parney IF, Mammoser A, Smith SM, Li J. Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting. Neurooncol Pract. 2022 Dec; 9 (6):552-558 Epub 2022 Sept 10
    View PubMed
  30. Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol. 2022 Dec 1; 8 (12):1809-1815
    View PubMed
  31. Bauman MMJ, Bouchal SM, Monie DD, Aibaidula A, Singh R, Parney IF. Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma. Neurosurg Focus. 2022 Dec; 53 (6):E14
    View PubMed
  32. Riviere-Cazaux C, Bhandarkar AR, Rahman M, Zheng CR, Bauman MMJ, Naylor RM, Van Gompel JJ, Zimmerman RS, White JJ, Parney IF, Chaichana KL, Miller KJ, Lehman VT, Kaufmann TJ, Burns TC. Outcomes and Principles of Patient Selection for Laser Interstitial Thermal Therapy for Metastatic Brain Tumor Management: A Multisite Institutional Case Series. World Neurosurg. 2022 Sep; 165:e520-e531 Epub 2022 June 26
    View PubMed
  33. Moassefi M, Faghani S, Conte GM, Kowalchuk RO, Vahdati S, Crompton DJ, Perez-Vega C, Cabreja RAD, Vora SA, Quiñones-Hinojosa A, Parney IF, Trifiletti DM, Erickson BJ. A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients. J Neurooncol. 2022 Sep; 159(2):447-455. Epub 2022 Jul 19.
    View PubMed
  34. Takami H, Graffeo CS, Perry A, Brown DA, Meyer FB, Burns TC, Parney IF. Presentation, imaging, patterns of care, growth, and outcome in sporadic and von Hippel-Lindau-associated central nervous system hemangioblastomas. J Neurooncol. 2022 Sep; 159 (2):221-231 Epub 2022 July 28
    View PubMed
  35. Goyal A, Zreik J, Brown DA, Kerezoudis P, Habermann EB, Chaichana KL, Chen CC, Bydon M, Parney IF. Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States. J Neurosurg. 2022 Jul 1; 137 (1):32-41 Epub 2021 Nov 12
    View PubMed
  36. Kerezoudis P, Puffer RC, Parney IF. Letter: The Morbidity and Mortality of Surgery for Traumatic Brain Injury in Geriatric Patients: A Study of Over 100 000 Patient Cases. Neurosurgery 2022 Jul 1; 91 (1):e20-e21 Epub 2022 May 02
    View PubMed
  37. Rivera Perla KM, Tang OY, Durfey SNM, Vivas-Buitrago T, Sherman WJ, Parney I, Uhm JH, Porter AB, Elinzano H, Toms SA, Quiñones-Hinojosa A. Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI). J Neurooncol. 2022 Jul; 158(3):349-357. Epub 2022 May 03.
    View PubMed
  38. Rahman M, Olson I, Mansour M, Carlstrom LP, Sutiwisesak R, Saber R, Rajani K, Warrington AE, Howard A, Schroeder M, Chen S, Decker PA, Sananikone EF, Zhu Y, Tchkonia T, Parney IF, Burma S, Brown D, Rodriguez M, Sarkaria JN, Kirkland JL, Burns TC. Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition. Mol Cancer Res. 2022 Jun 3; 20 (6):938-948
    View PubMed
  39. Tripathi S, Vivas-Buitrago T, Domingo RA, Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sherman W, Gupta V, Middlebrooks EH, Sabsevitz DS, Porter AB, Uhm JH, Bendok BR, Parney I, Meyer FB, Chaichana KL, Swanson KR, Quinones-Hinojosa A. IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model. J Neurosurg. 2022 Jun 1; 136 (6):1567-1575 Epub 2021 Oct 29
    View PubMed
  40. Chatzopoulos K, Eschbacher KL, Gurram PR, Huang J, Rinaldo L, Milone AA, Johnson DR, Shah AS, Wengenack NL, Schuetz AN, Parney IF, Trejo-Lopez JA. An 82-year-old man with a right frontal lobe rim-enhancing lesion. Brain Pathol. 2022 Mar; 32 (2):e13021 Epub 2021 Oct 04
    View PubMed
  41. Parney IF, Anderson SK, Gustafson MP, Steinmetz S, Peterson TE, Kroneman TN, Raghunathan A, O'Neill BP, Buckner JC, Solseth M, Dietz AB. Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac089. Epub 2022 Jun 24.
    View PubMed
  42. Magana SM, Peterson TE, Evans JE, Decker PA, Simon V, Eckel-Passow JE, Daniels DJ, Parney IF. Pediatric brain tumor cell lines exhibit miRNA-depleted, Y RNA-enriched extracellular vesicles. J Neurooncol. 2022 Jan; 156 (2):269-279 Epub 2022 Jan 05
    View PubMed
  43. Vivas-Buitrago T, Domingo RA, Tripathi S, De Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sabsevitz DS, Bendok BR, Sherman W, Parney IF, Jentoft ME, Middlebrooks EH, Meyer FB, Chaichana KL, Quinones-Hinojosa A. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. J Neurosurg. 2022 Jan 1; 136 (1):1-8 Epub 2021 June 04
    View PubMed
  44. Brown DA, Goyal A, Richter KR, Haglin JM, Himes BT, Lu VM, Snyder K, Hughes J, Decker PA, Opoku-Darko M, Link MJ, Burns TC, Parney IF. Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma. J Neurosurg. 2022 Jan 1; 136 (1):30-39 Epub 2021 July 02
    View PubMed
  45. Jung MY, Aibaidula A, Brown DA, Himes BT, Cumba Garcia LM, Parney IF. Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-gamma through PD-L1 and IDO1. Neurooncol Adv. 2022 Jan-Dec; 4 (1):vdac017 Epub 2022 Feb 15
    View PubMed
  46. Hasegawa H, Vakharia K, Link MJ, Stafford SL, Brown PD, Parney IF, Burns TC, Yan ES, Mahajan A, Laack NN, Pollock BE. The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience. J Neurooncol. 2021 Dec; 155 (3):335-342 Epub 2021 Oct 27
    View PubMed
  47. Marin BM, Porath KA, Jain S, Kim M, Conage-Pough JE, Oh JH, Miller CL, Talele S, Kitange GJ, Tian S, Burgenske DM, Mladek AC, Gupta SK, Decker PA, McMinn MH, Stopka SA, Regan MS, He L, Carlson BL, Bakken K, Burns TC, Parney IF, Giannini C, Agar NYR, Eckel-Passow JE, Cochran JR, Elmquist WF, Vaubel RA, White FM, Sarkaria JN. Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma. Neuro Oncol. 2021 Dec 1; 23 (12):2042-2053
    View PubMed
  48. Xu TT, Pulido JS, Parney IF, Ida CM, Dalvin LA, Olsen TW. Carbon Fiducial Markers for Tumor Localization in Stereotactic Irradiation of Uveal Melanoma. Ocul Oncol Pathol. 2021 Oct; 7 (5):368-375 Epub 2021 Aug 03
    View PubMed
  49. Puffer RC, Cumba Garcia LM, Himes BT, Jung MY, Meyer FB, Okonkwo DO, Parney IF. Plasma extracellular vesicles as a source of biomarkers in traumatic brain injury. J Neurosurg. 2021 Jun 1; 134 (6):1921-1928 Epub 2020 July 24
    View PubMed
  50. Teyateeti A, Geno CS, Stafford SS, Mahajan A, Yan ES, Merrell KW, Laack NN, Parney IF, Brown PD, Jethwa KR. Does the dural resection bed need to be irradiated? Patterns of recurrence and implications for postoperative radiotherapy for temporal lobe gliomas. Neurooncol Pract. 2021 Apr; 8 (2):190-198 Epub 2020 Nov 04
    View PubMed
  51. Mark IT, Black DF, DeLone DR, Passe TJ, Witte RJ, Little JT, Ho ML, Fagan AJ, Parney IF, Burns TC, Welker KM. Higher temporal resolution multiband fMRI provides improved presurgical language maps. Neuroradiology. 2021 Mar; 63(3):439-445. Epub 2020 Oct 06.
    View PubMed
  52. Vogelbaum MA, Parney IF, Elder JB, Cahill D. Neurosurgical involvement in clinical trials for CNS tumors. J Neurooncol. 2021 Feb; 151 (3):367-373 Epub 2021 Feb 21
    View PubMed
  53. Monie DD, Bhandarkar AR, Parney IF, Correia C, Sarkaria JN, Vile RG, Li H. Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma. Neurosurg Focus. 2021 Feb; 50(2):E10.
    View PubMed
  54. Himes BT, Geiger PA, Ayasoufi K, Bhargav AG, Brown DA, Parney IF. Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications. Front Oncol. 2021; 11:770561 Epub 2021 Oct 28
    View PubMed
  55. Renfrow JJ, Brown DA, Link MJ, Laack NN, Routman DM, Pollock BE, Parney IF. Salvage Radiosurgery for Recurrent Supratentorial Primitive Neuroectodermal Tumors: A Single Institutional Series and Review of the Literature. Stereotact Funct Neurosurg. 2021; 99 (5):405-411 Epub 2021 Apr 21
    View PubMed
  56. Bornschlegl S, Gustafson MP, Delivanis DA, Ryder M, Liu MC, Vasmatzis G, Hallemeier CL, Park SS, Roberts LR, Parney IF, Jelinek DF, Dietz AB. Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors. Clin Transl Immunology. 2021; 10(4):e1267. Epub 2021 Apr 29.
    View PubMed
  57. Renfrow JJ, Brown DA, Keating GF, Laack NN, Parney IF. Long-Term Control after Radiosurgery for a Recurrent Supratentorial Primitive Neuroectodermal Tumor: A Case Report and Review of the Literature. Stereotact Funct Neurosurg 2021; 99 (3):267-269 Epub 2020 Dec 16
    View PubMed
  58. Perry A, Graffeo CS, Carlstrom LP, Raghunathan A, Driscoll CLW, Neff BA, Carlson ML, Parney IF, Link MJ, Van Gompel JJ. Predominance of M1 subtype among tumor-associated macrophages in phenotypically aggressive sporadic vestibular schwannoma. J Neurosurg. 2020 Dec 1; 133 (6):1637-1645 Epub 2019 Oct 04
    View PubMed
  59. Ayasoufi K, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, Fain CE, Yokanovich LT, Himes BT, Jin F, Zheng J, Schuelke MR, Hansen MJ, Tung W, Parney IF, Pease LR, Vile RG, Johnson AJ. Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators. Brain. 2020 Dec 1; 143 (12):3629-3652
    View PubMed
  60. Graffeo CS, Parney IF, Wessel BL, Spinner RJ. In Reply to the Letter to the Editor Regarding "A Surprise Sabbatical: How Mayo Clinic Neurosurgery Coped with COVID-19". World Neurosurg 2020 Dec; 144:330
    View PubMed
  61. Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler JS, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve DC, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow SD. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Nov 02; 18(11):1537-1570.
    View PubMed
  62. Graffeo CS, Link MJ, Stafford SL, Parney IF, Foote RL, Pollock BE. Risk of internal carotid artery stenosis or occlusion after single-fraction radiosurgery for benign parasellar tumors. J Neurosurg. 2020 Nov 1; 133 (5):1388-1395 Epub 2019 Oct 25
    View PubMed
  63. Graffeo CS, Parney IA, Wessel B, Spinner RJ. A Surprise Sabbatical: How Mayo Clinic Neurosurgery Coped with Coronavirus Disease 2019. World Neurosurg. 2020 Nov; 143:26-27 Epub 2020 July 31
    View PubMed
  64. Kerezoudis P, Goyal A, Puffer RC, Parney IF, Meyer FB, Bydon M. Morbidity and mortality in elderly patients undergoing evacuation of acute traumatic subdural hematoma. Neurosurg Focus. 2020 Oct; 49 (4):E22
    View PubMed
  65. Hamilton MG, Parney I, Harris OA, Schmidt EA, Riina HA. Introduction. Cranial surgery in geriatric patients. Neurosurg Focus 2020 Oct; 49 (4):E1
    View PubMed
  66. Brown DA, Goyal A, Kerezoudis P, Alvi MA, Himes BT, Bydon M, Van Gompel JJ, Chaichana KL, Quinones-Hinojosa A, Burns TC, Yan E, Parney IF. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry. J Neurooncol. 2020 Sep; 149 (2):293-303 Epub 2020 Aug 28
    View PubMed
  67. Goyal A, Kerezoudis P, Yolcu YU, Chaichana KL, Abode-Iyamah K, Quinones-Hinojosa A, Bendok BR, Krauss WE, Parney IF, Spinner RJ, Van Gompel JJ, Bydon M. Letter to the Editor: Survey of Academic U.S. Programs Regarding the Impact of the COVID-19 Pandemic on Clinical Practice, Education, and Research in Neurosurgery. World Neurosurg 2020 Aug; 140:476-478 Epub 2020 June 10
    View PubMed
  68. Himes BT, Peterson TE, de Mooij T, Garcia LMC, Jung MY, Uhm S, Yan D, Tyson J, Jin-Lee HJ, Parney D, Abukhadra Y, Gustafson MP, Dietz AB, Johnson AJ, Dong H, Maus RL, Markovic S, Lucien F, Parney IF. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction. Neuro Oncol. 2020 Jul 7; 22 (7):967-978
    View PubMed
  69. Himes BT, Arnett AL, Merrell KW, Gates MJ, Bhargav AG, Raghunathan A, Brown DA, Burns TC, Parney IF. Glioblastoma Recurrence Versus Treatment Effect in a Pathology-Documented Series. Can J Neurol Sci. 2020 Jul; 47 (4):525-530 Epub 2020 Feb 20
    View PubMed
  70. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol. 2020 Jun 9; 22 (6):757-772
    View PubMed
  71. Ene CI, Kreuser SA, Jung M, Zhang H, Arora S, White Moyes K, Szulzewsky F, Barber J, Cimino PJ, Wirsching HG, Patel A, Kong P, Woodiwiss TR, Durfy SJ, Houghton AM, Pierce RH, Parney IF, Crane CA, Holland EC. Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma. Neuro Oncol. 2020 May 15; 22 (5):639-651
    View PubMed
  72. Brown DA, Lu VM, Himes BT, Burns TC, Quinones-Hinojosa A, Chaichana KL, Parney IF. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis. Clin Exp Metastasis. 2020 Apr; 37 (2):341-352 Epub 2020 Jan 16
    View PubMed
  73. Vaubel RA, Tian S, Remonde D, Schroeder MA, Mladek AC, Kitange GJ, Caron A, Kollmeyer TM, Grove R, Peng S, Carlson BL, Ma DJ, Sarkar G, Evers L, Decker PA, Yan H, Dhruv HD, Berens ME, Wang Q, Marin BM, Klee EW, Califano A, LaChance DH, Eckel-Passow JE, Verhaak RG, Sulman EP, Burns TC, Meyer FB, O'Neill BP, Tran NL, Giannini C, Jenkins RB, Parney IF, Sarkaria JN. Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma. Clin Cancer Res. 2020 Mar 1; 26 (5):1094-1104 Epub 2019 Dec 18
    View PubMed
  74. Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys. 2020 Feb 1; 106 (2):255-260 Epub 2019 Oct 22
    View PubMed
  75. Rinaldo L, Brown DA, Bhargav AG, Rusheen AE, Naylor RM, Gilder HE, Monie DD, Youssef SJ, Parney IF. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature. J Neurosurg. 2020 Jan 1; 132 (1):10-21 Epub 2019 Jan 04
    View PubMed
  76. de Mooij T, Peterson TE, Evans J, McCutcheon B, Parney IF. Short non-coding RNA sequencing of glioblastoma extracellular vesicles. J Neurooncol. 2020 Jan; 146 (2):253-263 Epub 2020 Jan 07
    View PubMed
  77. Parney IF, Gustafson MP, Solseth M, Bulur P, Peterson TE, Smadbeck JB, Johnson SH, Murphy SJ, Vasmatzis G, Dietz AB. Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma. Neurooncol Adv. 2020 Jan-Dec; 2 (1):vdaa105 Epub 2020 Aug 26
    View PubMed
  78. Goyal A, Yolcu YU, Goyal A, Kerezoudis P, Brown DA, Graffeo CS, Goncalves S, Burns TC, Parney IF. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Neurosurg Focus. 2019 Dec 1; 47 (6):E13
    View PubMed
  79. Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, Caron AA, Vaubel RA, Gupta SK, Kitange GJ, Sicotte H, Youland RS, Remonde D, Voss JS, Fritcher EGB, Kolsky KL, Ida CM, Meyer FB, Lachance DH, Parney IJ, Kipp BR, Giannini C, Sulman EP, Jenkins RB, Eckel-Passow JE, Sarkaria JN. Molecular profiling of long-term IDH-wildtype glioblastoma survivors. Neuro Oncol. 2019 Nov 4; 21 (11):1458-1469
    View PubMed
  80. Petrova L, Korfiatis P, Petr O, LaChance DH, Parney I, Buckner JC, Erickson BJ. Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma. J Neurol Sci. 2019 Oct 15; 405:116433 Epub 2019 Aug 23
    View PubMed
  81. Lu VM, Wahood W, Akinduro OO, Parney IF, Quinones-Hinojosa A, Chaichana KL. Four Independent Predictors of Postoperative Seizures After Meningioma Surgery: A Meta-Analysis. World Neurosurg. 2019 Oct; 130:537-545.e3 Epub 2019 June 19
    View PubMed
  82. Lu VM, Goyal A, Graffeo CS, Perry A, Burns TC, Parney IF, Quinones-Hinojosa A, Chaichana KL. Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis. World Neurosurg. 2019 Jul; 127:31-37 Epub 2019 Apr 01
    View PubMed
  83. Texakalidis P, Lu VM, Yolcu Y, Kerezoudis P, Alvi MA, Parney IF, Fogelson JL, Bydon M. Impact of Powdered Vancomycin on Preventing Surgical Site Infections in Neurosurgery: A Systematic Review and Meta-analysis. Neurosurgery. 2019 Mar 1; 84 (3):569-580
    View PubMed
  84. Zhang L, Peterson TE, Lu VM, Parney IF, Daniels DJ. Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells. PLoS One. 2019; 14 (7):e0220569 Epub 2019 July 30
    View PubMed
  85. Cumba Garcia LM, Peterson TE, Cepeda MA, Johnson AJ, Parney IF. Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma. Front Oncol. 2019; 9:651 Epub 2019 July 16
    View PubMed
  86. Rinaldo L, Brown D, Lanzino G, Parney IF. Outcomes following cerebrospinal fluid shunting in high-grade glioma patients. J Neurosurg. 2018 Oct; 129 (4):984-996 Epub 2017 Dec 22
    View PubMed
  87. Kurokawa C, Iankov ID, Anderson SK, Aderca I, Leontovich AA, Maurer MJ, Oberg AL, Schroeder MA, Giannini C, Greiner SM, Becker MA, Thompson EA, Haluska P, Jentoft ME, Parney IF, Weroha SJ, Jen J, Sarkaria JN, Galanis E. Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. J Natl Cancer Inst. 2018 Oct 1; 110 (10):1123-1132
    View PubMed
  88. Brown DA, Himes BT, Kerezoudis P, Chilinda-Salter YM, Grewal SS, Spear JA, Bydon M, Burns TC, Parney IF. Insurance correlates with improved access to care and outcome among glioblastoma patients. Neuro Oncol. 2018 Sep 03; 20(10):1374-1382.
    View PubMed
  89. ReFaey K, Tripathi S, Yoon JW, Justice J, Kerezoudis P, Parney IF, Bendok BR, Chaichana KL, Quinones-Hinojosa A. The reliability of YouTube videos in patients education for Glioblastoma Treatment. J Clin Neurosci. 2018 Sep; 55:1-4 Epub 2018 July 31
    View PubMed
  90. Kim M, Ma DJ, Calligaris D, Zhang S, Feathers RW, Vaubel RA, Meaux I, Mladek AC, Parrish KE, Jin F, Barriere C, Debussche L, Watters J, Tian S, Decker PA, Eckel-Passow JE, Kitange GJ, Johnson AJ, Parney IF, Anastasiadis PZ, Agar NYR, Elmquist WF, Sarkaria JN. Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier. Mol Cancer Ther. 2018 Sep; 17 (9):1893-1901 Epub 2018 July 03
    View PubMed
  91. Chen X, Zhang M, Gan H, Wang H, Lee JH, Fang D, Kitange GJ, He L, Hu Z, Parney IF, Meyer FB, Giannini C, Sarkaria JN, Zhang Z. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat Commun. 2018 Jul 27; 9 (1):2949 Epub 2018 July 27
    View PubMed
  92. Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, Hunt CH, Giannini C, Parney IF, Laack NN. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas. J Neurooncol. 2018 May; 137 (3):583-591 Epub 2018 Jan 13
    View PubMed
  93. Vaubel RA, Caron AA, Yamada S, Decker PA, Eckel Passow JE, Rodriguez FJ, Nageswara Rao AA, Lachance D, Parney I, Jenkins R, Giannini C. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation. Brain Pathol. 2018 Mar; 28 (2):172-182 Epub 2017 Apr 02
    View PubMed
  94. Bond KM, Hughes JD, Porter AL, Orina J, Fang S, Parney IF. Adult Pilocytic Astrocytoma: An Institutional Series and Systematic Literature Review for Extent of Resection and Recurrence. World Neurosurg. 2018 Feb; 110:276-283 Epub 2017 Nov 24
    View PubMed
  95. Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol. 2018 Jan 22; 20 (2):184-191
    View PubMed
  96. Rajani KR, Carlstrom LP, Parney IF, Johnson AJ, Warrington AE, Burns TC. Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma. Front Oncol. 2018; 8:656 Epub 2019 Feb 22
    View PubMed
  97. Routman DM, Yan E, Vora S, Peterson J, Mahajan A, Chaichana KL, Laack N, Brown PD, Parney IF, Burns TC, Trifiletti DM. Preoperative Stereotactic Radiosurgery for Brain Metastases. Front Neurol. 2018; 9:959 Epub 2018 Nov 13
    View PubMed
  98. Pepin KM, McGee KP, Arani A, Lake DS, Glaser KJ, Manduca A, Parney IF, Ehman RL, Huston J 3rd. MR Elastography Analysis of Glioma Stiffness and IDH1-Mutation Status. AJNR Am J Neuroradiol. 2018 Jan; 39(1):31-36. Epub 2017 Oct 26.
    View PubMed
  99. Brown DA, Himes BT, Major BT, Mundell BF, Kumar R, Kall B, Meyer FB, Link MJ, Pollock BE, Atkinson JD, Van Gompel JJ, Marsh WR, Lanzino G, Bydon M, Parney IF. Cranial Tumor Surgical Outcomes at a High-Volume Academic Referral Center. Mayo Clin Proc. 2018 Jan; 93 (1):16-24
    View PubMed
  100. Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, Fenstermaker RA, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Howard S, Junck L, Kaley T, Kumthekar P, Loeffler JS, Moots PL, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Ragsdale J 3rd, Rockhill J, Rogers L, Rusthoven C, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tsien C, Weiss S, Wen PY, Willmarth N, Bergman MA, Engh A. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017 Nov; 15 (11):1331-1345
    View PubMed
  101. Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ. Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status. J Digit Imaging. 2017 Oct; 30 (5):622-628
    View PubMed
  102. Akkus Z, Ali I, Sedlar J, Agrawal JP, Parney IF, Giannini C, Erickson BJ. Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence. J Digit Imaging. 2017 Aug; 30 (4):469-476
    View PubMed
  103. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 Aug; 18 (8):1049-1060 Epub 2017 July 04
    View PubMed
  104. Youland RS, Schomas DA, Brown PD, Parney IF, Laack NNI. Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience. J Neurooncol. 2017 Jun; 133 (2):339-346 Epub 2017 Apr 21
    View PubMed
  105. Buckner J, Giannini C, Eckel-Passow J, Lachance D, Parney I, Laack N, Jenkins R. Management of diffuse low-grade gliomas in adults - use of molecular diagnostics. Nat Rev Neurol. 2017 Jun; 13 (6):340-351 Epub 2017 May 12
    View PubMed
  106. Pollock BE, Link MJ, Stafford SL, Parney IF, Garces YI, Foote RL. The Risk of Radiation-Induced Tumors or Malignant Transformation After Single-Fraction Intracranial Radiosurgery: Results Based on a 25-Year Experience. Int J Radiat Oncol Biol Phys. 2017 Apr 1; 97 (5):919-923 Epub 2017 Jan 09
    View PubMed
  107. Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. AJNR Am J Neuroradiol. 2017 Apr; 38 (4):678-684 Epub 2017 Jan 26
    View PubMed
  108. Cheville AL, Basford JR, Parney I, Yang P, Diehn FE. Nested Cohort Study to Identify Characteristics That Predict Near-Term Disablement From Lung Cancer Brain Metastases. Arch Phys Med Rehabil. 2017 Feb; 98 (2):303-311.e1 Epub 2016 Sept 22
    View PubMed
  109. Gaba P, Puffer RC, Hoover JM, Wharen RE, Parney IF. Perioperative Outcomes in Intracranial Pleomorphic Xanthoastrocytoma. Neurosurgery. 2017 Jan 1; 80 (1):105-111
    View PubMed
  110. Arnett ALH, Reynolds MM, Pulido JS, Parney IF, Laack NN. Gamma Knife Stereotactic Radiosurgery for the Treatment of Primary and Metastatic Ocular Malignancies. Stereotact Funct Neurosurg. 2017; 95 (6):363-368 Epub 2017 Nov 04
    View PubMed
  111. Kumar R, de Mooij T, Peterson TE, Kaptzan T, Johnson AJ, Daniels DJ, Parney IF. Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane. PLoS One. 2017; 12 (6):e0179012 Epub 2017 June 30
    View PubMed
  112. Reynolds MM, Arnett AL, Parney IF, Kumar R, Laack NN, Maloney PR, Kozelsky TF, Garces YI, Foote RL, Pulido JS. Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases. Int J Retina Vitreous. 2017; 3:17 Epub 2017 May 29
    View PubMed
  113. Korfiatis P, Kline TL, Coufalova L, Lachance DH, Parney IF, Carter RE, Buckner JC, Erickson BJ. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas. Med Phys. 2016 Jun; 43 (6):2835-2844
    View PubMed
  114. McCutcheon BA, Ubl DS, Babu M, Maloney P, Murphy M, Murphy M, Kerezoudis P, Bydon M, Habermann EB, Parney I. Predictors of Surgical Site Infection Following Craniotomy for Intracranial Neoplasms: An Analysis of Prospectively Collected Data in the American College of Surgeons National Surgical Quality Improvement Program Database. World Neurosurg. 2016 Apr; 88:350-358 Epub 2015 Dec 29
    View PubMed
  115. Cockle JV, Rajani K, Zaidi S, Kottke T, Thompson J, Diaz RM, Shim K, Peterson T, Parney IF, Short S, Selby P, Ilett E, Melcher A, Vile R. Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling. Neuro Oncol. 2016 Apr; 18 (4):518-27 Epub 2015 Sept 26
    View PubMed
  116. Renner DN, Malo CS, Jin F, Parney IF, Pavelko KD, Johnson AJ. Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model. Neurotherapeutics. 2016 Jan; 13 (1):226-36
    View PubMed
  117. Ryken TC, Parney I, Buatti J, Kalkanis SN, Olson JJ. The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 2015 Dec; 125 (3):551-83 Epub 2015 Nov 03
    View PubMed
  118. Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM. Central Nervous System Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Oct; 13 (10):1191-202
    View PubMed
  119. Kumar R, Laack N, Pollock BE, Link M, O'Neill BP, Parney IF. Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma. World Neurosurg. 2015 Aug; 84: (2)390-7.
    View PubMed
  120. Zhang L, Zhang Z, Liu Y, Xue Y, Parney I. Programmed death-ligand 1 (PD-L1) may play a role in malignant glioma infiltration. Med Hypotheses. 2015 Aug; 85 (2):127-9 Epub 2015 Apr 20
    View PubMed
  121. Chae M, Peterson TE, Balgeman A, Chen S, Zhang L, Renner DN, Johnson AJ, Parney IF. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model. Neuro Oncol. 2015 Jul; 17 (7):978-91 Epub 2014 Dec 23
    View PubMed
  122. Handlogten KS, Sharpe EE, Brost BC, Parney IF, Pasternak JJ. Dexmedetomidine and Mannitol for Awake Craniotomy in a Pregnant Patient. Anesth Analg. 2015 May; 120 (5):1099-1103
    View PubMed
  123. Kelm ZS, Korfiatis PD, Lingineni RK, Daniels JR, Buckner JC, Lachance DH, Parney IF, Carter RE, Erickson BJ. Variability and accuracy of different software packages for dynamic susceptibility contrast magnetic resonance imaging for distinguishing glioblastoma progression from pseudoprogression. J Med Imaging (Bellingham). 2015 Apr; 2 (2):026001 Epub 2015 May 26
    View PubMed
  124. Renner DN, Jin F, Litterman AJ, Balgeman AJ, Hanson LM, Gamez JD, Chae M, Carlson BL, Sarkaria JN, Parney IF, Ohlfest JR, Pirko I, Pavelko KD, Johnson AJ. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses. PLoS One. 2015; 10 (5):e0125565 Epub 2015 May 01
    View PubMed
  125. Lester RA, Brown LC, Eckel LJ, Foote RT, NageswaraRao AA, Buckner JC, Parney IF, Wetjen NM, Laack NN. Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor. J Neurooncol. 2014 Nov; 120 (2):371-9 Epub 2014 Aug 13
    View PubMed
  126. Kizilbash SH, Giannini C, Voss JS, Decker PA, Jenkins RB, Hardie J, Laack NN, Parney IF, Uhm JH, Buckner JC. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. J Neurooncol. 2014 Oct; 120 (1):85-93 Epub 2014 July 04
    View PubMed
  127. Murphy M, Parney IF. Clinical trials in neurosurgical oncology. J Neurooncol. 2014 Sep; 119 (3):569-76 Epub 2014 Aug 09
    View PubMed
  128. Halling G, Giannini C, Britton JW, Lee RW, Watson RE Jr, Terrell CL, Parney IF, Buckingham EM, Carpenter JE, Grose C. Focal encephalitis following varicella-zoster virus reactivation without rash in a healthy immunized young adult. J Infect Dis. 2014 Sep 1; 210 (5):713-6 Epub 2014 Mar 05
    View PubMed
  129. Call JA, Naik M, Rodriguez FJ, Giannini C, Wu W, Buckner JC, Parney IF, Laack NN. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma. Am J Clin Oncol. 2014 Feb; 37 (1):1-7
    View PubMed
  130. Youland RS, Brown PD, Giannini C, Parney IF, Uhm JH, Laack NN. Adult low-grade glioma: 19-year experience at a single institution. Am J Clin Oncol. 2013 Dec; 36 (6):612-9
    View PubMed
  131. Roberts DJ, Jenne CN, Leger C, Kramer AH, Gallagher CN, Todd S, Parney IF, Doig CJ, Yong VW, Kubes P, Zygun DA. A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans. J Neurotrauma. 2013 Oct 15; 30(20):1717-26. Epub 2013 Sep 06.
    View PubMed
  132. Roberts DJ, Jenne CN, Leger C, Kramer AH, Gallagher CN, Todd S, Parney IF, Doig CJ, Yong VW, Kubes P, Zygun DA. Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury in humans. J Neurotrauma. 2013 Oct 15; 30(20):1727-36. Epub 2013 Aug 28.
    View PubMed
  133. Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013 Aug; 15 (8):1058-67 Epub 2013 Mar 03
    View PubMed
  134. Youland RS, Schomas DA, Brown PD, Nwachukwu C, Buckner JC, Giannini C, Parney IF, Laack NN. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol. 2013 Aug; 15 (8):1102-10 Epub 2013 June 27
    View PubMed
  135. Hoover JM, Nwojo M, Puffer R, Mandrekar J, Meyer FB, Parney IF. Surgical outcomes in recurrent glioma: clinical article. J Neurosurg. 2013 Jun; 118(6):1224-31. Epub 2013 Mar 15.
    View PubMed
  136. Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg. 2013 Apr; 118 (4):786-98 Epub 2012 Nov 23
    View PubMed
  137. Mallory GW, Fang S, Giannini C, Van Gompel JJ, Parney IF. Brain carcinoid metastases: outcomes and prognostic factors. J Neurosurg. 2013 Apr; 118 (4):889-95 Epub 2013 Feb 08
    View PubMed
  138. Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J, Lachance DH, Parney IF. Gliomatosis cerebri: clinical characteristics, management, and outcomes. J Neurooncol. 2013 Apr; 112 (2):267-75 Epub 2013 Jan 23
    View PubMed
  139. Lee DW, Ramakrishnan D, Valenta J, Parney IF, Bayless KJ, Sitcheran R. The NF-kappaB RelB protein is an oncogenic driver of mesenchymal glioma. PLoS One. 2013; 8(2):e57489. Epub 2013 Feb 25.
    View PubMed
  140. Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol. 2013 Jan; 111 (1):11-8 Epub 2012 Oct 20
    View PubMed
  141. Tanaka S, Puffer RC, Hoover JM, Goerss SJ, Haugen LM, McGee K, Parney IF. Increased frameless stereotactic accuracy with high-field intraoperative magnetic resonance imaging. Neurosurgery. 2012 Dec; 71(2 Suppl Operative):ons321-7; discussion ons327-8.
    View PubMed
  142. Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF. Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma. J Neurooncol. 2012 Nov; 110 (2):227-35 Epub 2012 Aug 09
    View PubMed
  143. Roberge D, Parney I, Brown PD. Radiosurgery to the postoperative surgical cavity: who needs evidence? Int J Radiat Oncol Biol Phys. 2012 Jun 1; 83(2):486-93. Epub 2011 Nov 16.
    View PubMed
  144. Bower RS, Daugherty WP, Giannini C, Parney IF. Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia. Surg Neurol Int. 2012; 3:151 Epub 2012 Dec 14
    View PubMed
  145. Parney IF. Basic concepts in glioma immunology. Adv Exp Med Biol. 2012; 746:42-52
    View PubMed
  146. Parney IF, Berger MS. Principles of brain tumor surgery. Handb Clin Neurol. 2012; 104:187-213.
    View PubMed
  147. Olin MR, Andersen BM, Litterman AJ, Grogan PT, Sarver AL, Robertson PT, Liang X, Chen W, Parney IF, Hunt MA, Blazar BR, Ohlfest JR. Oxygen is a master regulator of the immunogenicity of primary human glioma cells. Cancer Res. 2011 Nov 1; 71(21):6583-9. Epub 2011 Sep 09.
    View PubMed
  148. Hamilton MG, Roldan G, Magliocco A, McIntyre JB, Parney I, Easaw JC. Determination of the methylation status of MGMT in different regions within glioblastoma multiforme. J Neurooncol. 2011 Apr; 102(2):255-60. Epub 2010 Jul 21.
    View PubMed
  149. Hoover JM, Chang SM, Parney IF. Clinical trials in brain tumor surgery. Neuroimaging Clin N Am. 2010 Aug; 20(3):409-24.
    View PubMed
  150. Kelly JJ, Blough MD, Stechishin OD, Chan JA, Beauchamp D, Perizzolo M, Demetrick DJ, Steele L, Auer RN, Hader WJ, Westgate M, Parney IF, Jenkins R, Cairncross JG, Weiss S. Oligodendroglioma cell lines containing t(1;19)(q10;p10). Neuro Oncol. 2010 Jul; 12(7):745-55. Epub 2010 Apr 13.
    View PubMed
  151. Parney IF, Goerss SJ, McGee K, Huston J 3rd, Perkins WJ, Meyer FB. Awake craniotomy, electrophysiologic mapping, and tumor resection with high-field intraoperative MRI. World Neurosurg. 2010 May; 73 (5):547-51
    View PubMed
  152. Rodrigues JC, Gonzalez GC, Zhang L, Ibrahim G, Kelly JJ, Gustafson MP, Lin Y, Dietz AB, Forsyth PA, Yong VW, Parney IF. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol. 2010 Apr; 12 (4):351-65 Epub 2009 Dec 22
    View PubMed
  153. Lwu S, Hamilton MG, Forsyth PA, Cairncross JG, Parney IF. Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neurooncol. 2010 Feb; 96(3):403-8. Epub 2009 Aug 08.
    View PubMed
  154. Roldan GB, Scott JN, McIntyre JB, Dharmawardene M, de Robles, Magliocco AM, Yan ES, Parney IF, Forsyth PA, Cairncross JG, Hamilton MG, Easaw JC. Population-based study of pseudoprogression after chemoradiotherapy in GBM. Can J Neurol Sci. 2009 Sep; 36(5):617-22.
    View PubMed
  155. Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL, Forsyth P, Auer RN, Dunn JF, Cairncross JG, Parney IF, Weiss S. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells. 2009 Aug; 27(8):1722-33.
    View PubMed
  156. Lu JQ, Scheithauer BW, Sharma P, Scott JN, Parney IF, Hader W, Burger PC, Clark AW. Multifocal complex glioneuronal tumor in an elderly man: an autopsy study: case report. Neurosurgery. 2009 Jun; 64(6):E1193-5; discussion E1195.
    View PubMed
  157. Parney IF, Waldron JS, Parsa AT. Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J Neurosurg. 2009 Mar; 110(3):572-82.
    View PubMed
  158. Sijben AE, McIntyre JB, Roldan GB, Easaw JC, Yan E, Forsyth PA, Parney IF, Magliocco AM, Bernsen H, Cairncross JG. Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol. 2008 Aug; 89(1):97-103. Epub 2008 Apr 09.
    View PubMed
  159. Roldan G, Scott J, George D, Parney I, Easaw J, Cairncross G, Forsyth P, Yan E. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis. Can J Neurol Sci. 2008 May; 35(2):204-9.
    View PubMed
  160. Brown R, Zlatescu M, Sijben A, Roldan G, Easaw J, Forsyth P, Parney I, Sevick R, Yan E, Demetrick D, Schiff D, Cairncross G, Mitchell R. The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma. Clin Cancer Res. 2008 Apr 15; 14(8):2357-62.
    View PubMed
  161. Parney IF, Sloan AE. Outcomes in neurosurgical oncology. Congress Quarterly. 2008 Spr; 23-6.
  162. Toth C, Martin L, Morrish W, Coutts S, Parney I. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab. Acta Neurol Scand. 2007 Oct; 116(4):259-62.
    View PubMed
  163. Johnston AL, Lun X, Rahn JJ, Liacini A, Wang L, Hamilton MG, Parney IF, Hempstead BL, Robbins SM, Forsyth PA, Senger DL. The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol. 2007 Aug; 5(8):e212.
    View PubMed
  164. Smith JS, Parney IF, Lamborn KR, McDermott MW, Sneed PK, Chang SM. Treatment for posterior fossa dissemination of primary supratentorial glioma. J Neurosurg. 2007 Apr; 106(4):567-74.
    View PubMed
  165. Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2007 Jan; 13(1):84-8. Epub 2006 Dec 10.
    View PubMed
  166. Lun X, Senger DL, Alain T, Oprea A, Parato K, Stojdl D, Lichty B, Power A, Johnston RN, Hamilton M, Parney I, Bell JC, Forsyth PA. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas. J Natl Cancer Inst. 2006 Nov 1; 98(21):1546-57.
    View PubMed
  167. Parney IF, Chang LJ, Farr-Jones MA, Hao C, Smylie M, Petruk KC. Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas. J Neurooncol. 2006 May; 78(1):71-80. Epub 2006 Apr 21.
    View PubMed
  168. Tihan T, Barletta J, Parney I, Lamborn K, Sneed PK, Chang S. Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol. 2006 Mar; 37(3):272-82.
    View PubMed
  169. Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER, Glioma Outcomes Project Investigators. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005 Feb 2; 293(5):557-64.
    View PubMed
  170. Parney IF, Kunwar S, McDermott M, Berger M, Prados M, Cha S, Croteau D, Puri RK, Chang SM. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg. 2005 Feb; 102(2):267-75.
    View PubMed
  171. Parsa AT, Lee J, Parney IF, Weinstein P, McCormick PC, Ames C. Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. J Neurooncol. 2004 Aug-Sep; 69(1-3):291-318.
    View PubMed
  172. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S, Glioma Outcomes Investigators. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003 Sep; 99(3):467-73.
    View PubMed
  173. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M, Glioma Outcomes Investigators. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003 Jun; 98(6):1175-81.
    View PubMed
  174. Parney IF, Chang SM. Current chemotherapy for glioblastoma. Cancer J. 2003 May-Jun; 9(3):149-56.
    View PubMed
  175. Parney IF, Chang LJ. Cancer immunogene therapy: a review. J Biomed Sci. 2003 Jan-Feb; 10(1):37-43.
    View PubMed
  176. Parney IF, Farr-Jones MA, Kane K, Chang LJ, Petruk KC. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12. Can J Neurol Sci. 2002 Aug; 29(3):267-75.
    View PubMed
  177. Parney IF, Farr-Jones MA, Koshal A, Chang LJ, Petruk KC. Human brain tumor cell culture characterization after immunostimulatory gene transfer. Neurosurgery. 2002 May; 50(5):1094-102.
    View PubMed
  178. Hao C, Parney IF, Roa WH, Turner J, Petruk KC, Ramsay DA. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol. 2002 Feb; 103(2):171-8. Epub 2001 Nov 22.
    View PubMed
  179. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW, Parney IF, Roa WH, Petruk KC. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res. 2001 Feb 1; 61(3):1162-70.
    View PubMed
  180. Parney IF, Allen PB, Petruk KC. Howard H. Hepburn and the development of skull tongs for cervical spine traction. Neurosurgery. 2000 Dec; 47(6):1430-2; discussion 1432-3.
    View PubMed
  181. Parney IF, Steinke DE. Heparin-induced thrombocytopenia and thrombosis following subarachnoid hemorrhage. Case report. J Neurosurg. 2000 Jul; 93(1):136-9.
    View PubMed
  182. Parney IF, Farr-Jones MA, Chang LJ, Petruk KC. Human glioma immunobiology in vitro: implications for immunogene therapy. Neurosurgery. 2000 May; 46(5):1169-77;discussion 1177-8.
    View PubMed
  183. Parney IF, Hao C, Petruk KC. Glioma immunology and immunotherapy. Neurosurgery. 2000 Apr; 46(4):778-91; discussion 791-2.
    View PubMed
  184. Gainer AL, Young ATL, Parney IF, Petruk KC, Elliott JF. Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF. J Neurooncol. 2000 Mar; 47(1):23-30.
    View PubMed
  185. Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, Moore RB. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer. 1999 Oct; 81(4):638-46.
    View PubMed
  186. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg. 1999 Jun; 90(6):1105-14.
    View PubMed
  187. Farr-Jones MA, Parney IF, Petruk KC. Improved technique for establishing short term human brain tumor cultures. J Neurooncol. 1999 May; 43(1):1-10.
    View PubMed
  188. Parney IF, Johnson ES, Allen PB. "Idiopathic" cranial hypertrophic pachymeningitis responsive to antituberculous therapy: case report. Neurosurgery. 1997 Oct; 41(4):965-71.
    View PubMed
  189. Parney IF, Petruk KC, Zhang C, Farr-Jones M, Sykes DB, Chang LJ. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model. Hum Gene Ther. 1997 Jun 10; 8(9):1073-85.
    View PubMed
PST-20225141